OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting signaling pathways in prostate cancer: mechanisms and clinical trials
Yundong He, Weidong Xu, Yu‐Tian Xiao, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 125
Yundong He, Weidong Xu, Yu‐Tian Xiao, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 125
Showing 1-25 of 125 citing articles:
Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease
Vivek Panwar, Aishwarya Singh, Manini Bhatt, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 304
Vivek Panwar, Aishwarya Singh, Manini Bhatt, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 304
Single-cell analysis of multiple cancer types reveals differences in endothelial cells between tumors and normal tissues
Jiayu Zhang, Tong Lü, Shiqi Lu, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 21, pp. 665-676
Open Access | Times Cited: 38
Jiayu Zhang, Tong Lü, Shiqi Lu, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 21, pp. 665-676
Open Access | Times Cited: 38
AR and PI3K/AKT in Prostate Cancer: A Tale of Two Interconnected Pathways
Elisabetta Tortorella, Sabrina Giantulli, Alessandro Sciarra, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2046-2046
Open Access | Times Cited: 38
Elisabetta Tortorella, Sabrina Giantulli, Alessandro Sciarra, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2046-2046
Open Access | Times Cited: 38
Addressing the Reciprocal Crosstalk between the AR and the PI3K/AKT/mTOR Signaling Pathways for Prostate Cancer Treatment
Fabio Raith, Daniel H. O’Donovan, Clara Lemos, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2289-2289
Open Access | Times Cited: 23
Fabio Raith, Daniel H. O’Donovan, Clara Lemos, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2289-2289
Open Access | Times Cited: 23
Biological determinants of PSMA expression, regulation and heterogeneity in prostate cancer
Martin Bakht, Himisha Beltran
Nature Reviews Urology (2024)
Closed Access | Times Cited: 14
Martin Bakht, Himisha Beltran
Nature Reviews Urology (2024)
Closed Access | Times Cited: 14
Lung regeneration: diverse cell types and the therapeutic potential
Yutian Chen, Zhen Li, Gaili Ji, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 11
Yutian Chen, Zhen Li, Gaili Ji, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 11
Dual targeting of the androgen receptor and PI3K /AKT /mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosis
Tatsuo Sugawara, Ekaterina Nevedomskaya, Simon Heller, et al.
Molecular Oncology (2024) Vol. 18, Iss. 3, pp. 726-742
Open Access | Times Cited: 10
Tatsuo Sugawara, Ekaterina Nevedomskaya, Simon Heller, et al.
Molecular Oncology (2024) Vol. 18, Iss. 3, pp. 726-742
Open Access | Times Cited: 10
Molecular Mechanisms of Prostate Cancer Development in the Precision Medicine Era: A Comprehensive Review
Shigekatsu Maekawa, Ryo Takata, Wataru Obara
Cancers (2024) Vol. 16, Iss. 3, pp. 523-523
Open Access | Times Cited: 9
Shigekatsu Maekawa, Ryo Takata, Wataru Obara
Cancers (2024) Vol. 16, Iss. 3, pp. 523-523
Open Access | Times Cited: 9
Small Molecule‐Drug Conjugates: Opportunities for the Development of Targeted Anticancer Drugs
Jingjing Zhang, Fanchun Hu, Ömer Aras, et al.
ChemMedChem (2024) Vol. 19, Iss. 11
Closed Access | Times Cited: 9
Jingjing Zhang, Fanchun Hu, Ömer Aras, et al.
ChemMedChem (2024) Vol. 19, Iss. 11
Closed Access | Times Cited: 9
Advances in prostate-specific membrane antigen-targeted theranostics: from radionuclides to near-infrared fluorescence technology
Zhongji Jiang, Gaohaer Kadeerhan, Jin Zhang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Zhongji Jiang, Gaohaer Kadeerhan, Jin Zhang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Hit to lead optimization of the 4-trifluoromethylquinoline derivatives as novel SGK1 inhibitors with potent anti-prostate cancer activity
Cheng Li, Sha Cheng, Jia Yu, et al.
European Journal of Medicinal Chemistry (2025), pp. 117336-117336
Closed Access | Times Cited: 1
Cheng Li, Sha Cheng, Jia Yu, et al.
European Journal of Medicinal Chemistry (2025), pp. 117336-117336
Closed Access | Times Cited: 1
MAPK inhibitor sensitivity scores predict sensitivity driven by the immune infiltration in pediatric low-grade gliomas
Romain Sigaud, Thomas Albert, Caroline Heß, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 18
Romain Sigaud, Thomas Albert, Caroline Heß, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 18
Advances in landscape and related therapeutic targets of the prostate tumor microenvironment
Duocai Li, Weidong Xu, Yifan Chang, et al.
Acta Biochimica et Biophysica Sinica (2023) Vol. 55, Iss. 6, pp. 956-973
Open Access | Times Cited: 15
Duocai Li, Weidong Xu, Yifan Chang, et al.
Acta Biochimica et Biophysica Sinica (2023) Vol. 55, Iss. 6, pp. 956-973
Open Access | Times Cited: 15
CRISPR screening reveals gleason score and castration resistance related oncodriver ring finger protein 19 A (RNF19A) in prostate cancer
Ning Zhang, Da Huang, Xiaohao Ruan, et al.
Drug Resistance Updates (2023) Vol. 67, pp. 100912-100912
Open Access | Times Cited: 14
Ning Zhang, Da Huang, Xiaohao Ruan, et al.
Drug Resistance Updates (2023) Vol. 67, pp. 100912-100912
Open Access | Times Cited: 14
Identifying potential therapeutic targets for prostate cancer with mediating role in tumor immunity
Zhechun Wu, Sihan Li, Yuqing Li, et al.
Research Square (Research Square) (2025)
Open Access
Zhechun Wu, Sihan Li, Yuqing Li, et al.
Research Square (Research Square) (2025)
Open Access
From past to present: tracing the trends of diabetes drug trials in mainland China
Zengqing Ma, Xin Zhao, Yu Lin, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access
Zengqing Ma, Xin Zhao, Yu Lin, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access
Advancements in molecular imaging probes for precision diagnosis and treatment of prostate cancer
Jiajie Fang, Ahmad Alhaskawi, Yanzhao Dong, et al.
Journal of Zhejiang University SCIENCE B (2025)
Closed Access
Jiajie Fang, Ahmad Alhaskawi, Yanzhao Dong, et al.
Journal of Zhejiang University SCIENCE B (2025)
Closed Access
Effective therapeutic targeting of tumor lineage plasticity in neuroendocrine prostate cancer by BRD4 inhibitors
Xiong Zhang, Yatian Yang, Hongye Zou, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Xiong Zhang, Yatian Yang, Hongye Zou, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Molecular pathways in reproductive cancers: a focus on prostate and ovarian cancer
Ayodeji Folorunsho Ajayi, Mega O. Oyovwi, Oyedayo Phillips Akano, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Ayodeji Folorunsho Ajayi, Mega O. Oyovwi, Oyedayo Phillips Akano, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
A circRNA–mRNA pairing mechanism regulates tumor growth and endocrine therapy resistance in ER-positive breast cancer
Yi Jia, Jiao Du, Xue Chen, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 8
Open Access
Yi Jia, Jiao Du, Xue Chen, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 8
Open Access
Functional Study of Four Histone Genes Involved in the Spermatogenesis of Cynoglossus semilaevis
Xun Sun, Zhijie Li, Lijun Wang, et al.
Animals (2025) Vol. 15, Iss. 4, pp. 593-593
Open Access
Xun Sun, Zhijie Li, Lijun Wang, et al.
Animals (2025) Vol. 15, Iss. 4, pp. 593-593
Open Access
Overcoming drug resistance in castrate-resistant prostate cancer: current mechanisms and emerging therapeutic approaches
Adam Khorasanchi, Feng Hong, Yuanquan Yang, et al.
Cancer Drug Resistance (2025)
Open Access
Adam Khorasanchi, Feng Hong, Yuanquan Yang, et al.
Cancer Drug Resistance (2025)
Open Access
Cyclin-Dependent Kinase Inhibition in Prostate Cancer: Past, Present, and Future
Matthew Siskin, Minas P. Economides, David R. Wise
Cancers (2025) Vol. 17, Iss. 5, pp. 774-774
Open Access
Matthew Siskin, Minas P. Economides, David R. Wise
Cancers (2025) Vol. 17, Iss. 5, pp. 774-774
Open Access
Current Evidence on Cabazitaxel for Prostate Cancer Therapy: A Narrative Review
Kazuhiro Suzuki, Hideyasu Matsuyama, Nobuaki Matsubara, et al.
International Journal of Urology (2025)
Open Access
Kazuhiro Suzuki, Hideyasu Matsuyama, Nobuaki Matsubara, et al.
International Journal of Urology (2025)
Open Access
Emerging roles of EGFL family members in neoplastic diseases: Molecular mechanisms and targeted therapies
Xiaoge Gao, G.-L. Zhang, Feitong Wang, et al.
Biochemical Pharmacology (2025) Vol. 236, pp. 116847-116847
Closed Access
Xiaoge Gao, G.-L. Zhang, Feitong Wang, et al.
Biochemical Pharmacology (2025) Vol. 236, pp. 116847-116847
Closed Access
